PAREXEL International Corporation Company Profile

09:02 EDT 20th September 2017 | BioPortfolio

PAREXEL International Corporation is a leading contract research and medical marketing services organization providing a broad spectrum of services from first-in-human clinical studies through product launch to the pharmaceutical, biotechnology, and medical device industries around the world. The Company's primary objective is to help clients quickly obtain the necessary regulatory approvals of their products and, ultimately, optimize the market penetration of those products. Over the past fifteen years, PAREXEL has developed significant expertise in disciplines supporting this strategy. The Company's service offerings include: clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, performance improvement, industry training and publishing, and other drug development consulting services. The Company believes that its integrated services, therapeutic area depth, and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths.


195 West Street
United States of America


Phone: 781 487-9900
Fax: (781) 487-0525

News Articles [473 Associated News Articles listed on BioPortfolio]

PAREXEL International to be acquired by Pamplona Capital Management

PAREXEL International Corporation, a leading global biopharmaceutical services provider, and Pamplona Capital Management, announced that they have entered into a definitive agreement under which Pampl...

Pamplona to buy US firm Parexel International for $5bn

Pamplona Capital Management has agreed to acquire US-based biopharmaceutical services provider Parexel International for around $5bn.

Parexel International Taken by Pamplona

US drug development company Parexel International is being acquired by private equity group Pamplona Capital Management in a deal valued at approximately $5 billion, including debt.

PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Release

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2017 on Monday, August 28, 2017, after the close of the stoc...

Parexel, Osaka International Cancer Institute partner in Japan

Parexel International, a global biopharmaceutical services provider, and Osaka International Cancer Institute have formed an alliance to advance clinical development in Japan. The partnership will aim...

PAREXEL International Corporation Strategy, SWOT and Corporate Finance Report [Report Updated: 03082017] Prices from USD $175

PAREXEL International Corporation Strategy, SWOT and Corporate Finance ReportSummaryPAREXEL International Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive compan...

PAREXEL International Enters Definitive Agreement to Be Acquired by Pamplona Capital Management ...

For PAREXELMedia:Mark StephensonTel.: +1 781-434-4783Email: Mark.Stephenson@PAREXEL.comorBarrett Golden / Arielle RothsteinJoele Frank, Wilkinson Brimmer KatcherTel.: +1 212-355-4...

Parexel to be acquired by PE in $5bn deal

Parexel International Corporation has signed a definite agreement to be acquired by the private equity firm Pamplona Capital Management, LLP.

Clinical Trials [783 Associated Clinical Trials listed on BioPortfolio]

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial ...

Valiant Evo International Clinical Trial

The purpose of the Valiant Evo International Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thor...

Companies [1412 Associated Companies listed on BioPortfolio]

KMI Parexel

KMI, a division of PAREXEL International, LLC offers worldwide regulatory services to the pharmaceutical, biopharmaceutical and medical device industries. Employing an impressive team of former FDA in...


Perceptive is a subsidiary of PAREXEL International Corporation, one of the world's largest biopharmaceutical outsourcing organizations. PAREXEL's committment to comprehensive services resulted in the...

PAREXEL Consulting

Founded in 1983 An independent consulting unit of PAREXEL International A leading life sciences consulting firm Exclusively focused on the life sciences industry Primarily serving the pharmaceutical, ...

PAREXEL International Corporation

PAREXEL International Corporation is a leading contract research and medical marketing services organization providing a broad spectrum of services from first-in-human clinical studies through product...

Service Corporation International

Service Corporation International (NYSE: SCI), headquartered in Houston, Texas, is North America’s leading provider of deathcare products and services. At June 30, 2010, we o...

More Information about "PAREXEL International Corporation" on BioPortfolio

We have published hundreds of PAREXEL International Corporation news stories on BioPortfolio along with dozens of PAREXEL International Corporation Clinical Trials and PubMed Articles about PAREXEL International Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PAREXEL International Corporation Companies in our database. You can also find out about relevant PAREXEL International Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record